UnitedHealth Q2 2026 EPS $6.04 GAAP, $6.38 adjusted; raises full-year guidance

UNITEDHEALTH GROUP INC

Q2 revenues $112.0B (flat YoY); earnings from operations $8.0B vs $5.2B in Q2 2025.
GAAP EPS $6.04, adjusted EPS $6.38; medical cost ratio improved to 86.7% from 89.4%.
UnitedHealthcare operating margin 4.6% (vs 2.4% YoY); Optum margin 6.2% (vs 4.6%).
Full-year adjusted EPS guidance raised to $19.50-$20.00 from prior >$17.75; cash flow ops guidance ~$24B.
Share repurchase target increased to at least $5B for 2026; debt-to-capital ratio 41.2%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.